EichorEICHOR
Location: Sacramento Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Sacramento

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · University of California Davis (UC Davis) Comprehensive Canc · Eli Lilly and Company · NCT07218380A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-10024 Sacramento, CA Investigational Site · Colorado Prevention Center · NCT06024746Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · UC Davis Medical Center · Joseph Broderick, MD · NCT07227246Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Sutter Health - Sutter Institute for Medical Research · Bristol-Myers Squibb · NCT07106762MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Kaiser Permanente Downtown Commons · National Cancer Institute (NCI) · NCT05564390Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
Phase 2 · University of California Davis Health (UC Davis Health) · Montefiore Medical Center · NCT05184842Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Sutter Medical Center Sacramento · National Cancer Institute (NCI) · NCT06172296Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Sutter Medical Center Sacramento · NRG Oncology · NCT05624996A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · UC Davis Health Medical Center · Pfizer · NCT07073820A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · University of California Davis Comprehensive Cancer Center · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With
Phase 1/Phase 2 · UC Davis Cancer Center · Hoffmann-La Roche · NCT05987449Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
NA · University of California Davis Health · Ad scientiam · NCT05566769A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · UC Davis Department of Dermatology · Takeda · NCT07108283A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · University of California Davis Comprehensive Cancer Center · National Cancer Institute (NCI) · NCT05691478EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
Phase 1/Phase 2 · VA Northern California Health Care System, Mather, CA · VA Office of Research and Development · NCT05467748A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Phase 1 · University of California Davis Comprehensive Cancer Center · Clasp Therapeutics, Inc. · NCT06778863Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally A
Phase 1/Phase 2 · University of California Davis Comprehensive Cancer Center · National Cancer Institute (NCI) · NCT04172532Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment
NA · University of California Davis Emergency Department · University of California, Davis · NCT07024498Post-Market Study to Assess iTind Safety in Comparison to UroLift
NA · Golden State Urology · Olympus Corporation of the Americas · NCT04757116Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astr
Phase 1 · University of California Davis Comprehensive Cancer Center · National Cancer Institute (NCI) · NCT06860594Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Can
Phase 2 · University of California Davis Comprehensive Cancer Center · National Cancer Institute (NCI) · NCT05691465Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
Phase 1/Phase 2 · University of California Davis · EicOsis Human Health Inc. · NCT07142044Prospective Evaluation of Topical Almond Oil vs Hydroquinone
Phase 4 · UC Davis Department of Dermatology, Clinical Trials Unit · University of California, Davis · NCT04875715LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)
NA · University of California, Davis · University of California, Davis · NCT06103682Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Mercy Cancer Center - Sacramento · Alliance for Clinical Trials in Oncology · NCT07091617Digital Monitoring for Patients Post Coronary Interventions to Reduce Risk for Recurrent Adverse Cardiovascular Events
NA · University of California, Davis Medical Center Division of C · University of California, Davis · NCT06114615Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Interventio
NA · University of California, Davis - Dermatology Department · University of California, Davis · NCT06574178Decolonization to Reduce After-Surgery Events of Surgical Site Infection
Phase 4 · University of California, Davis Medical Center · University of California, Irvine · NCT05586776Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Chang
Phase 1 · University of California Davis Comprehensive Cancer Center · National Cancer Institute (NCI) · NCT05372614A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · Retinal Consultants Medical Group Inc · Astellas Pharma Global Development, Inc. · NCT06779773
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.